TrialCPT: pharmacometrics & systems pharmacology2020

Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated Pain.

Ahmed Abbas Suleiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.